Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows From Operating Activities
Net loss	$ (4,492,309)	$ (3,049,525)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	44,512	207,073
Amortization of operating lease right-of-use assets	534,710	571,534
Write down of inventories	41,635	132,329
Stock based compensation expense	622,930	290,655
Research and development	1,962,000
Changes in bad debt allowance	749	(2,222)
Changes in operating assets and liabilities:
Accounts receivable	(80,551)	222,189
Advance to suppliers	(38,938)	(54,010)
Inventories	(273,198)	2,857,461
Other current assets	895,015	680,545
Operating lease liabilities	(534,266)	(560,171)
Accounts payable	30,637	166,968
Advance from customers	185,403	44,332
Accrued liabilities and other payables	(26,659)	(47,061)
Taxes payable		60,050
Net Cash (Used in) Provided by Operating Activities	(1,128,330)	1,520,147
Cash Flows From Investing Activity
Purchase of intangible assets		(2,437,727)
Net Cash Used in Investing Activity		(2,437,727)
Cash Flows From Financing Activities
Proceed from loan from a shareholder	360,000
Proceed from issuing common stocks	600,000
Net Cash Provided by Financing Activities	960,000
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(38,522)	292,422
Net Decrease in Cash and Cash Equivalents	(206,852)	(625,158)
Cash and Cash Equivalents, Beginning of Period	369,137	1,374,167
Cash and Cash Equivalents, Ending of Period	162,285	749,009
Supplemental Disclosure of Cash Flow Information
Income tax payments	5,087	202,288
Interest expense	$ 4,860	$ 4,780